These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35752307)

  • 21. Baseline Toxicity Model to Identify the Specific and Nonspecific Effects of Per- and Polyfluoroalkyl Substances in Cell-Based Bioassays.
    Qin W; Henneberger L; Glüge J; König M; Escher BI
    Environ Sci Technol; 2024 Apr; 58(13):5727-5738. PubMed ID: 38394616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
    Takacs ML; Abbott BD
    Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transactivation potencies of the Baikal seal (Pusa sibirica) peroxisome proliferator-activated receptor α by perfluoroalkyl carboxylates and sulfonates: estimation of PFOA induction equivalency factors.
    Ishibashi H; Kim EY; Iwata H
    Environ Sci Technol; 2011 Apr; 45(7):3123-30. PubMed ID: 21381677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach.
    Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF
    Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying novel mechanisms of per- and polyfluoroalkyl substance-induced hepatotoxicity using FRG humanized mice.
    Robarts DR; Paine-Cabrera D; Kotulkar M; Venneman KK; Gunewardena S; Foquet L; Bial G; Apte U
    Arch Toxicol; 2024 Sep; 98(9):3063-3075. PubMed ID: 38782768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of legacy and novel perfluoroalkyl substances on human cytochrome P450: An in vitro study on the inhibitory potential and underlying mechanisms.
    Amstutz VH; Cengo A; Sijm DTHM; Vrolijk MF
    Toxicology; 2022 Feb; 468():153116. PubMed ID: 35121066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
    Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
    J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of legacy and emerging per- and polyfluoroalkyl substances on PPARα/β/γ regulation and osteogenic/adipogenic differentiation.
    Qin H; Niu Y; Luan H; Li M; Zheng L; Pan Y; Liu W
    Environ Int; 2022 Dec; 170():107584. PubMed ID: 36265359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional effects of binary combinations of PFAS in FaO cells.
    Bjork JA; Dawson DA; Krogstad JO; Wallace KB
    Toxicology; 2021 Dec; 464():152997. PubMed ID: 34695511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA.
    Heintz MM; Chappell GA; Thompson CM; Haws LC
    Front Toxicol; 2022; 4():937168. PubMed ID: 35832492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose additive maternal and offspring effects of oral maternal exposure to a mixture of three PFAS (HFPO-DA, NBP2, PFOS) during pregnancy in the Sprague-Dawley rat.
    Conley JM; Lambright CS; Evans N; Farraj AK; Smoot J; Grindstaff RD; Hill D; McCord J; Medlock-Kakaley E; Dixon A; Hines E; Gray LE
    Sci Total Environ; 2023 Sep; 892():164609. PubMed ID: 37271399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumorigenic activity of alternative per- and polyfluoroalkyl substances (PFAS): Mechanistic in vitro studies.
    Pierozan P; Cattani D; Karlsson O
    Sci Total Environ; 2022 Feb; 808():151945. PubMed ID: 34843762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic Transcriptome Comparative In Silico Analysis Reveals Similar Pathways and Targets Altered by Legacy and Alternative Per- and Polyfluoroalkyl Substances in Mice.
    Robarts DR; Dai J; Lau C; Apte U; Corton JC
    Toxics; 2023 Nov; 11(12):. PubMed ID: 38133364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perfluoroalkyl substances and immunotoxicity: An in vitro structure-activity relationship study in THP-1-derived monocytes and macrophages.
    Amstutz VH; Sijm DTHM; Vrolijk MF
    Chemosphere; 2024 Sep; 364():143075. PubMed ID: 39151576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
    Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
    Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agonistic and potentiating effects of perfluoroalkyl substances (PFAS) on the Atlantic cod (Gadus morhua) peroxisome proliferator-activated receptors (Ppars).
    Søderstrøm S; Lille-Langøy R; Yadetie F; Rauch M; Milinski A; Dejaegere A; Stote RH; Goksøyr A; Karlsen OA
    Environ Int; 2022 May; 163():107203. PubMed ID: 35364415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
    Mazzucotelli A; Viguerie N; Tiraby C; Annicotte JS; Mairal A; Klimcakova E; Lepin E; Delmar P; Dejean S; Tavernier G; Lefort C; Hidalgo J; Pineau T; Fajas L; Clément K; Langin D
    Diabetes; 2007 Oct; 56(10):2467-75. PubMed ID: 17646210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contamination and effects of perfluorochemicals in Baikal seal (Pusa sibirica). 2. Molecular characterization, expression level, and transcriptional activation of peroxisome proliferator-activated receptor alpha.
    Ishibashi H; Iwata H; Kim EY; Tao L; Kannan K; Tanabe S; Batoev VB; Petrov EA
    Environ Sci Technol; 2008 Apr; 42(7):2302-8. PubMed ID: 18504957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structural basis for the activation of peroxisome proliferator-activated receptor gamma (PPARγ) by perfluorooctanoic acid (PFOA).
    Pederick JL; Frkic RL; McDougal DP; Bruning JB
    Chemosphere; 2024 Apr; 354():141723. PubMed ID: 38494006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.